Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Total Revenue of $704.0 thousand for fiscal year 2025.
Harvard Apparatus Regenerative Technology, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $704.0K +63.7% |
$430.0K +317.5% |
$103.0K | — | $0.00 | $0.00 |
| Revenue (ASC 606) | $704.0K +63.7% |
$430.0K +317.5% |
$103.0K | — | — | — |
| Net Income | -$6.87M +11.2% |
-$7.73M +13.6% |
-$8.95M -47.3% |
-$6.07M +23.9% |
-$7.98M -64.0% |
-$4.87M +41.6% |
| Diluted EPS | — | — | -$0.67 -21.8% |
-$0.55 +30.4% |
-$0.79 -43.6% |
-$0.55 |
| Total Assets | $2.68M -39.7% |
$4.44M +69.9% |
$2.61M +8.9% |
$2.40M +28.6% |
$1.87M -10.1% |
$2.08M +4.2% |
| Cash and Equivalents | $1.35M -45.6% |
$2.49M +475.5% |
$432.0K -65.2% |
$1.24M | — | — |
| Stockholders Equity | $1.06M -67.2% |
$3.22M +95.7% |
$1.65M +151.6% |
-$3.19M -5.3% |
-$3.03M -369.2% |
$1.12M +3.3% |
| R&D Expense | $2.65M +14.8% |
$2.31M -24.6% |
$3.06M +75.8% |
$1.74M +9.4% |
$1.59M -23.1% |
$2.07M -57.4% |
| Operating Income | -$6.92M +10.5% |
-$7.73M +14.1% |
-$8.99M -46.1% |
-$6.15M +28.8% |
-$8.64M -62.2% |
-$5.33M +40.0% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 17.58M +10.4% |
15.92M +14.1% |
13.95M +14.6% |
12.17M +13.1% |
10.76M +14.6% |
9.39M +15.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $123.0K | +108.5% | -61.2% |
| Revenue (ASC 606) | September 30, 2025 | $123.0K | +108.5% | -61.2% |
| Net Income | September 30, 2025 | -$1.70M | +8.6% | +6.7% |
| Diluted EPS | September 30, 2024 | -$0.12 | +0.0% | +33.3% |
| Total Assets | September 30, 2025 | $2.55M | -52.1% | +19.1% |
| Cash and Equivalents | September 30, 2025 | $1.32M | -63.3% | +67.8% |
| Stockholders Equity | September 30, 2025 | $1.55M | -59.5% | +104.2% |
| R&D Expense | September 30, 2025 | $655.0K | +17.6% | -6.0% |
| Operating Income | September 30, 2025 | -$1.71M | +7.8% | +6.5% |
| Gross Profit | September 30, 2017 | $0.00 | -100.0% | — |
| Shares Outstanding | September 30, 2025 | 17.17M | +7.9% | +7.9% |
- Harvard Apparatus Regenerative Technology, Inc. reported Total Revenue of $704.0 thousand for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +63.7% in Total Revenue compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Revenue (ASC 606) of $704.0 thousand for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +63.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Net Income of -$6.87 million for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +11.2% in Net Income compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Diluted EPS of $0.67 per share (loss) for fiscal year 2023.
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -21.8% in Diluted EPS compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Total Assets of $2.68 million for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -39.7% in Total Assets compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Cash and Equivalents of $1.35 million for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -45.6% in Cash and Equivalents compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Stockholders Equity of $1.06 million for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -67.2% in Stockholders Equity compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported R&D Expense of $2.65 million for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +14.8% in R&D Expense compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Operating Income of -$6.92 million for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +10.5% in Operating Income compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Gross Profit of -$34.0 thousand for fiscal year 2016.
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -61.9% in Gross Profit compared to the prior fiscal year.
- Harvard Apparatus Regenerative Technology, Inc. reported Shares Outstanding of 17.58 million shares for fiscal year 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +10.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: